CliffBio
small molecule

FIBRICOR

FENOFIBRIC ACID

Loss of exclusivityAugust 2027latest FDA-listed patent expiry
CompanyRosemont Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameFIBRICOR
Active ingredientFENOFIBRIC ACID
Strength35MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2009
Marketing statusDISCN

Listed patents

PatentExpiresType
7569612August 2027use U-1000
7741374August 2027use U-1060
7741373August 2027use U-1059
7915247August 2027use U-1000

More from Rosemont Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

FIBRICOR patent cliff — loss of exclusivity August 2027 | CliffBio